A Study to Evaluate the Efficacy and Safety of AD-221 and AD-221A
Clinical trial NCT05131997 · COMPLETED
Trial details
- NCT number
- NCT05131997
- Sponsor
- Addpharma Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-16
- Primary completion
- 2022-06-08
- Enrollment
- 290
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.